Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial (Q34116445)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Sengwee Toh

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sonia Hernández-Díaz

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Roger Logan

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jacques E Rossouw

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Miguel A Hernán

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Annals of Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

152

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

211-217

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

5 July 2018

Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

5 July 2018

Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

5 July 2018

Estrogen therapy and coronary-artery calcification.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

5 July 2018

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

5 July 2018

Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

5 July 2018

Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

5 July 2018

Estrogen plus progestin and the risk of coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

5 July 2018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

5 July 2018

Marginal structural models and causal inference in epidemiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

5 July 2018

Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

5 July 2018

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

5 July 2018

On the treatment of grouped observations in life studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

5 July 2018

Causal inference from longitudinal studies with baseline randomization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

28 October 2018

Hormones and heart disease in women: the timing hypothesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

28 October 2018

Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

28 October 2018

Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

28 October 2018

Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936769

28 October 2018

Evaluation of cardiovascular event rates with hormone therapy in healthy, early postmenopausal women: results from 2 large clinical trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20157135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Executive summary. Hormone therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20157135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HRT and the young at heart

1 reference

https://pubmed.ncbi.nlm.nih.gov/20157135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of epoetin dose on hematocrit

1 reference

https://pubmed.ncbi.nlm.nih.gov/20157135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HRT in the early menopause: scientific evidence and common perceptions

1 reference

https://pubmed.ncbi.nlm.nih.gov/20157135

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.7326/0003-4819-152-4-201002160-00005

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34116445&oldid=1629919581"